Shawn Seong
Chief Executive Officer Shaperon
Professor Seung-Yong Seong is a Professor of Microbiology and Immunology at Seoul National University College of Medicine and a leading immunologist known for his seminal work on the DAMPs theory. He is the Founder and CEO of Shaperon Inc., where he has designed proprietary GPCR19-based immunomodulatory platforms, as well as the oncology-focused NanoMab platform for nanobody therapies. With experience across academia, government R&D policy, and industry, he oversees translational development from discovery through clinical trials, bridging fundamental immunology and next-generation therapeutic modalities.
Seminars
Tuesday 9th June 2026
Learning How to Conduct Bioanalysis for Bispecific ADCs to Accurately Understand the Molecule as a Whole
12:00 pm
- Understanding how different components affect the analysis and how that differs from a traditional ADC
- Exploring the differences in bioanalysis from traditional ADCs and how that can be adapted for bispecific ADCs
- Integrating multiple analytical technologies to gain a holistic understanding of pharmacokinetics and stability of the molecule
Thursday 11th June 2026
Discussing NanoMabs as a Modular Platform for Next-Generation Bispecific & NanoMab-Drug Conjugates
1:30 pm
- Defining the medical and technical unmet needs in bispecific antibodies and ADCs
- Addressing the unmet needs through NanoMab (nanobody-based) solutions
- Outlining the potential market impact and future implications of NanoMab-enabled therapeutics
